Small Cap Feast

Small Cap Feast – 20 July 2020

Dish of the Day:

No Joiners Today


Off the Menu:

No Leavers Today


What’s Cooking in the IPO Kitchen?

AEX Gold (TSXV:AEV) is intending to admit its shares to AIM alongside a £45m placing. The Company, led by CEO Eldur Ólafsson, has established the largest land package of gold assets in Greenland with a current portfolio of licences covering 3,356 square kilometres, in the two known gold belts in Southern Greenland, the Nanortalik and Tartoq gold belts. Nalunaq is a high-grade gold asset with an updated Inferred Mineral Resource covering 422,770 tonnes at 18.5 grams per tonne of gold, or 250,970 ounces of gold, which covers the area in and around the historical mine.  Due July.  Current mkt cap C$66.7m.


Breakfast Buffet

DXS International* 7p £3.14m (AQSE:DXSP)

FY Apr 20 results from the healthcare information and digital clinical decision support systems provider,

Profit after tax rose nearly five-fold to £428,502, compared to £85,096 in the previous year. 

Operating Profit of £308,423 (2019: Loss £137,228) achieved mainly due to a reduction in overhead for completed projects.

Turnover remained steady at £3,279,787 (2019: £3,346,343) in spite of the unprecedented interruption to business as usual during the last quarter of the financial year. 

New equity of over £1 million raised in February 2020 to be applied to launch and ongoing development of new solutions.

Cash at bank £1,010,645 as of 30 April 2020.

Operational Highlights

DXS’ Point of Care solution re-accredited for the new NHS Digital Framework to receive central NHS funding. 

New Expert Hypertension solution, earmarked for UK and International markets completed and ready for launch.


MJ Hudson 49p £83.9m (MJH.L)

MJ Hudson, the international asset management consultancy, updated following the end of its financial year to 30 June 2020

Group underlying revenue grew by 24% to approximately £20.8m in the year to June 2020 (FY2019: £16.7m). This figure includes maiden contributions from acquisitions Spring, AST and most recently Meyler. Over 92% of underlying revenue growth was recurring in nature

Management continues to expect the Group’s profits for FY 2020 to be in line with market expectations.

On an organic basis, underlying revenue grew by 7.4% year on year. This compares with 12.5% organic growth in the first half (against the same period in the prior year), before the impact of the Covid-19 pandemic.


Karelian Diamonds 2.85p £1.2m (KDR.L)

The National Land Survey of Finland has granted rights of way over the entire Naviskangas private forest road, together with a side road, giving vehicular access to the Company’s Lahtojoki diamond deposit, the adjacent Lahtojoki South exploration permit area and the surrounding reservation in the Kaavi region of Finland.

The granting of vehicular rights of way will facilitate the Company in its technical assessment of the Lahtojoki diamond deposit over which it has been granted a mining concession.

The two hectare Lahtojoki diamond deposit is located in the Kaavi region of Eastern Finland and lies in the Karelian Craton (Baltic Shield) which extends across north-eastern Russia and northern Finland. The world class Lomonosov and Grib Pipe diamond deposits have been discovered in the Russian sector of the Craton.


Lok’n Store 625p £185m (LOK.L)

The self-storage company, announced the agreement of a one-year extension to its existing joint banking facility with Royal Bank of Scotland plc and Lloyds Bank plc. The £75 million five-year revolving credit facility which was executed last year included two extension options, one of which has now been implemented. The facility which was due to expire in April 2024, will now run until April 2025 providing funding for more landmark site acquisitions. 

The £75 million five-year revolving credit facility set the interest rate margin at the London Inter-Bank Offer Rate (LIBOR) plus 1.50%-1.75% based on a loan to value covenant test. This rate is 1.50% currently and the current all in debt cost on £51.2 million drawn is averaging 1.6%-1.7%. The facility also provides for a £25 million accordion uplift to £100 million.


Global Petroleum 1.45p £2.9m (GBP.L)

Updated estimate of Prospective Resources for PEL0094 (Block 2011A), offshore Namibia, after interpretation of the 3D seismic data survey recently licensed from the Namibian State Oil Company, NAMCOR, which also holds a carried interest of 17% in the Licence. Global holds a working interest of 78% and is operator. 

A total of 881 million barrels of unrisked gross Prospective Resources (Best Estimate) has been estimated in PEL0094 in two prospects, of which 687 million barrels are net to Global. These have been classified in accordance with the Society of Petroleum Engineers Petroleum Resources Management System (SPE-PRMS), and have been estimated using a probabilistic method. The Prospective Resources are based on the 3D and 2D seismic data and geological information, including analogues, to which Global has access.

As expected, the interpretation of the 3D seismic data has led to increased confidence in the two prospects previously identified, Marula and Welwitschia Deep.


Rockfire Resources 1.025p £7.7m (ROCK.L)

Diamond drilling down to 500m depth is now underway at the Company’s 100%-owned Plateau Gold Deposit (“Plateau”), part of the Lighthouse tenement in North Queensland, Australia.


  • Six diamond drill holes are currently planned to test the gold mineralisation down to 500m vertical depth.
  • This is the fourth drilling programme since October 2019, which continues the Company’s aggressive exploration strategy, aimed at discovering a large economic gold deposit at Plateau. 
  • Assay results from the June 2020 reverse circulation drilling programme are still pending. The market will be updated once the results are received from the laboratory. 
  • The six planned deeper holes are expected to be completed over the coming months.


Synairgen 133.5p £200m (SNG.L)

Synairgen announces positive results from trial of SNG001 in hospitalised COVID-19 patients

Patients who received SNG001 had a 79% lower risk of developing severe disease compared to placebo  

Patients who received SNG001 were more than twice as likely to recover from COVID-19 as those on placebo


Tungsten Corp 39.3p £49.6m (TUNG.L)

The provider of digital financial management products and software solutions, issued a trading update ahead of the announcement on 7 September 2020 of its full-year results for the year ended 30 April 2020.

  • Group revenue grew 2% to £36.8 million; excluding Tungsten Network Finance1 (TNF), revenue grew 3% to £36.3 million
  • 93% of revenue was repeatable and recurring, up from 92% in FY19
  • Net cash of £3.2m compares with £1.0 million reported at the half year.  Positive full year cash generation of £0.4 million driven by strong working capital management
  •     Adjusted EBITDA for FY20 expected to be broadly in line with market guidance
  • New sales billings of £4.0 million were flat to prior year, although the second half run rate accelerated by 35% following our investments to strengthen our sales capabilities


Gama Aviation 38p £24m (GMAA.L)

Gama Aviation, the global business aviation service provider, has been awarded new special mission contracts for air ambulance provision by the Government of Guernsey and by the Government of Jersey. The contracts have an initial term of five years with options to extend by up to five years.

Operating Beechcraft King Air B200 aircraft, the Group will provide H24/365 services between the Channel Islands and UK mainland health services, providing a critical lifeline for the citizens of the islands. Gama Aviation will additionally provide medical teams to provide clinical services for the Guernsey operation.

The award comes shortly after Gama Aviation’s commencement of helicopter emergency services operations in Scotland, augmenting its fixed wing operations for the Scottish Ambulance Service.


Tern 9.65p £27.34m (TERN.L)

The investment company specialising in the Internet of Things (“IoT”), announces that it has raised £1.5 million before expenses  at 8.5p.  The funds raised via the Subscription are intended to be used to facilitate a new investment to expand Tern’s portfolio and will also:

  • provide additional working capital generally; and
  • facilitate follow-on investment opportunities in Tern’s principal portfolio companies as appropriate


62% year-on-year increase in turnover of principal portfolio companies1 for H1 2020. The Directors view this as an important positive result given the slow down across the economy during this period


Head Chef:

Derren Nathan
0203 764 2344

*A corporate client of Hybridan LLP


This document, which does not constitute research, has been issued by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to any such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific person or entity and is not a personal recommendation to any such person or entity. Recipients should reach an individual investment decision, based upon their respective financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.

The information contained in this document is based on materials and sources that are believed to be reliable; however, such information has not been independently verified and therefore it is not possible to confirm such information as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information contained in this document, nor should it be relied upon as such.

The content of this document includes market commentary and other information which we have prepared in relation to the company referred to in this document, which is our broking client. The provision of this document to you constitutes a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of Regulation 600/2014/EU (MIFID II Regulation).

Any and all opinions expressed are current as of the date appearing on this face of this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.

This document should not be relied upon as being an independent or impartial view of the subject matter and, for the avoidance of doubt, constitutes non-independent research (as such term is defined in the Financial Conduct Authority’s Conduct of Business Sourcebook to reflect the requirements of the MIFID II Regulation and Directive 2014/65/EU (known as MIFID II)). The individuals who prepared this document may be interested in shares in the company concerned and/or other companies within its sector, may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.

In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are each a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority’s Conduct of Business Sourcebook) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as relevant persons). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority’s Conduct of Business Sourcebook.

Neither this document, nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom, the United States or any other jurisdiction in any part of the world.

Where possible this document is made available to all relevant recipients at the same time. Dissemination of research by Hybridan LLP is monitored to ensure that it is only provided to relevant persons. Research prepared by Hybridan LLP is not intended to be received and/or used by any person who is a retail client.

Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.

This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.

MIFID II status of Hybridan LLP research
The cost of production of our corporate research is met by retainers from our corporate broking clients. In addition, from time to time we issue further communications as market commentary (such as our daily newsletter, Small Cap Breakfast), which we consider to constitute a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of the MIFID II Regulation.

Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.

If you would like to unsubscribe, please email with “unsubscribe me”.